Skip to main content
OpenTrials
Completed

NCT Number: NCT00370786

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Choroidal Neovascularization Angioid Streaks Choroid Diseases Eye Diseases Metaplasia Neovascularization, Pathologic Pathologic Processes Pathological Conditions, Signs and Symptoms Retinal Diseases Uveal Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Hamid Ahmadieh, MD

Tehran, Tehran Province, 16666, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.

Exclusion criteria

  • Evidence of AMD

Treatment and study plan

Bevacizumab

Drug

Primary outcomes

  1. Visual acuity

    Time frame: 6 months

Secondary outcomes

  1. central macular thickness

    Time frame: 6 months

  2. leakage in fluorescein angiography

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Important dates

Study start
2005
Primary completion
2007
Study completion
2008
First posted
Sep 1, 2006
Registry last updated
Jul 11, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.